Sakar Healthcare

Sakar Healthcare

375.30
-14.80
(-3.79%)
ann
Q1 Quarterly Results are out. Check out the updated financials1 day ago
Viewcross
right
hide
Key Fundamentals
Add Ratio
Market Cap
835.00 Cr
EPS
7.97
PE Ratio
42.79
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
394.95
52 Week Low
210.10
PB Ratio
2.75
Debt to Equity
0.30
Forecast For
Actual

Company News

View All News
Caret
positive
Sakar Healthcare has obtained nine new marketing authorizations for cancer products in Europe and emerging markets, increasing its total authorizations to eleven. The approved products include Carboplatin, Docetaxel, and Tamoxifen, which are treatments used in cancer therapy.
positive
Sakar Healthcare reported a net profit of Rs 46.7 million for Q1, marking a significant increase from Rs 24 million in the same period last year. The company's EBITDA grew to Rs 127 million from Rs 107 million year-over-year. However, the EBITDA margin declined to 24.1% from 26% in the previous year's corresponding quarter.
positive
Sakar Healthcare has expanded its export potential by receiving approvals for anti-cancer injections in Europe. The company has obtained its third and fourth marketing authorizations for oncology injections in the European market. Sakar Healthcare is preparing for commercial supply of these products to Europe.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,691.40
#1 4,05,823.50
38.74
#1 54,729.00
9.71
#1 10,980
2.89
55.98
6,656.50
1,76,709.20
71.11
9,712.00
18.67
2,191
35.10
58.39
1,505.70
1,21,623.50
22.36
28,409.50
7.12
5,291
3.71
40.84
3,580.00
1,21,163.50
60.51
11,539.40
6.99
1,911
30.46
50.54
1,205.40
1,00,604.30
#1 17.53
33,741.20
16.73
5,725
-0.38
37.06
944.10
94,998.60
18.88
23,511.00
18.55
4,615
34.60
33.87
2,261.80
93,357.70
52.66
12,744.20
#1 20.90
2,007
-21.05
25.15
1,971.80
90,062.90
20.71
22,909.50
13.74
3,306
#1 72.75
53.33
5,668.50
67,775.40
29.08
13,458.30
3.70
2,216
21.39
63.91
1,123.80
65,270.50
19.24
32,345.60
9.43
3,484
3.81
53.78
Growth Rate
Revenue Growth
14.31 %
Net Income Growth
49.57 %
Cash Flow Change
39.07 %
ROE
37.75 %
ROCE
19.78 %
EBITDA Margin (Avg.)
7.42 %

Quarterly Financial Results

Quarterly Financials
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Revenue
20
26
27
22
31
32
30
38
29
31
35
43
41
35
38
44
42
43
44
50
53
59
Expenses
16
19
23
15
24
25
23
28
21
22
25
33
30
25
28
32
31
31
32
35
40
46
EBITDA
5
7
4
8
7
8
7
10
8
9
11
10
11
10
9
12
11
12
12
16
13
13
Operating Profit %
23 %
27 %
14 %
33 %
21 %
22 %
22 %
25 %
28 %
28 %
26 %
19 %
23 %
27 %
24 %
25 %
26 %
27 %
27 %
31 %
24 %
20 %
Depreciation
1
1
1
5
2
2
3
3
4
4
4
4
5
4
4
5
5
5
5
6
6
6
Interest
1
1
1
0
1
1
1
1
1
1
2
2
2
2
2
2
1
2
1
4
2
2
Profit Before Tax
3
6
2
2
4
5
3
6
4
4
5
4
4
4
3
5
5
5
6
6
5
5
Tax
1
1
1
1
0
3
3
-3
1
3
1
0
1
1
1
2
2
0
1
1
1
1
Net Profit
3
5
2
2
4
3
0
9
3
2
4
4
3
4
2
3
2
5
5
6
5
5
EPS in ₹
1.72
3.04
1.20
1.17
2.15
1.44
0.07
5.07
1.65
1.01
2.16
2.04
1.46
1.68
0.98
1.46
1.10
2.17
2.08
2.66
2.11
2.03

Balance Sheet

Balance Sheet
2020
2021
2022
2023
2024
2025
Total Assets
115
178
268
336
389
415
Fixed Assets
66
69
205
267
314
309
Current Assets
22
34
50
56
72
89
Capital Work in Progress
13
49
1
7
0
17
Investments
0
0
7
3
0
0
Other Assets
36
60
55
60
74
90
Total Liabilities
115
178
268
336
389
415
Current Liabilities
14
33
47
55
59
63
Non Current Liabilities
20
46
94
109
67
67
Total Equity
81
99
128
173
262
286
Reserve & Surplus
66
83
110
154
236
261
Share Capital
15
16
17
19
22
22

Cash Flow

Cash Flow
2020
2021
2022
2023
2024
2025
Net Cash Flow
-0
-0
-0
0
0
-0
Investing Activities
-22
-47
-90
-74
-52
-31
Operating Activities
19
15
36
33
25
34
Financing Activities
4
32
55
41
27
-4

Share Holding

% Holding
Feb 2021
Mar 2021
Apr 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Jul 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Promoter
74.02 %
74.02 %
67.54 %
67.54 %
67.54 %
67.54 %
67.54 %
67.54 %
62.10 %
62.10 %
62.10 %
60.72 %
60.72 %
54.15 %
53.15 %
53.15 %
53.15 %
53.15 %
53.58 %
53.58 %
52.86 %
52.86 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
13.76 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
10.62 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
16.44 %
15.57 %
16.21 %
17.43 %
19.40 %
19.35 %
18.95 %
19.38 %
17.82 %
17.67 %
17.62 %
18.41 %
18.13 %
16.37 %
16.61 %
16.78 %
16.80 %
16.88 %
15.75 %
15.93 %
15.86 %
16.01 %
Others
9.54 %
10.41 %
16.25 %
15.03 %
13.06 %
13.12 %
13.51 %
13.09 %
20.09 %
20.24 %
20.29 %
20.87 %
21.15 %
29.48 %
5.86 %
30.07 %
30.05 %
29.97 %
30.67 %
30.48 %
31.28 %
31.13 %
No of Share Holders
2,049
307
2,444
4,604
6,481
6,542
6,702
6,091
6,092
5,678
6,210
6,322
6,056
6,057
7,001
7,386
7,313
7,867
8,598
8,608
8,115
7,565

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
20 Dec 2023 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
20 Dec 2023 393.70 372.25
21 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
21 Sept 2024 332.50 325.20
22 Oct 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
22 Oct 2024 317.60 317.50
08 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
08 Feb 2025 272.55 274.80
15 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
15 May 2025 269.05 310.75
07 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
07 Nov 2025 361.20 390.10

Technical Indicators

RSI(14)
Neutral
57.48
ATR(14)
Volatile
16.90
STOCH(9,6)
Neutral
58.89
STOCH RSI(14)
Neutral
69.58
MACD(12,26)
Bullish
1.71
ADX(14)
Strong Trend
35.43
UO(9)
Bearish
47.40
ROC(12)
Uptrend And Accelerating
2.84
WillR(14)
Neutral
-56.85